Integrin αvβ8 on T cells suppresses anti-tumor immunity in multiple models and is a promising target for tumor immunotherapy.

There was also a trend toward elevation of IFNγ and Foxp3 expression in CD4+ T cells that did not reach statistical significance ( Figure S6C ).

also in 111,027 other papers